Journal of Chest Surgery

The Korean Society for Thoracic and Cardiovascular Surgery (대한심장혈관흉부외과학회)
권호 표지

A Experimental Study of PTEN (Phosphatase and Tensin) Role in Mesothelioma

중피종에서 PTEN(Phosphatase and Tensin)의 역할에 대한 실험적 연구

  • 이석기 (조선대학교 의과대학 흉부외과학교실) ;
  • 김권천 (조선대학교 의과대학 외과학교실)
  • Published : 2003.11.01
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Conventional treatment for mesothelioma is largely ineffective. We evaluated the novel approach of adenoviral gene transfection of PTEN gene in mesothelioma cancer cell lines, inflammatory and epithelial subtype, which are sensitive to adenoviral p53. Material and Method: Binary adenoviral PTEN and LacZ (Ad/GT-LacZ and Ad/GV16) vectors were used for transduction of the mesothelioma cell lines, REN (p53 sensitive). Protein levels were determined by Western blotting assay. Apoptosis was assessed by fluorescence-activated cell sorter analysis of subdiploid populations. Cell viability was determined with the XTT assay. Statistical analysis was performed with analysis of variance and the Student t test. Result: 72 hours after the treatment of adenoviral PTEN gene, cell killing were 32.9% for REN compared to control cell (2.5%) at MOI of 20. Also we observed the over-expression of proapoptotic protein, bax and decreased expression of bcl-2 protein in REN cells. But the expression of BCL-xl, Bak, Bad proteins were not altered. Conclusion: Adenovirus Pten-mediated overexpression of the Bax gene induces apoptosis and decreased cellular viability in p53-sensitive mesothelioma cells. These data suggest that the transfection of PTEN gene may represent a alternative gene therapy strategy to treat mesothelioma.

배경: 중피종은 일반적 치료에 대하여 큰 효과가 없다고 알려져 있다. 저자들은 Adenoviral p53에 민감하게 반응하는 중피종 세포주인 염증 및 표피세포 아유형(subtype)에 adenovirus유전자 핵산전달감염(transfection)으로 중피종 치료의 새로운 방법에 대하여 평가하고자 하였다. 대상 및 방법: 두 쌍의 adenoviral PTEN와 LacZ (Ad/GT-LacZ와 Ad/GV16) 매개체(vectors)에 REN (p53 sensitive)인 중피종 세포주(methothelioma cell lines)의 형질을 도입(transduction)하였으며, 단백질 함량은 Western blotting 분석을 이용하여 측정하였다. 세포사멸은 fluorescence-activated cell sorter analysis of subdiploid populations에 의하여 평가하였으며, 세포 생존력은 XTT 분석에 의하여 결정하였다. 통계 분석은 analysis of variance와 Student t test를 이용하여 하였다. 결과: Adenoviral PTEN 유전자로 처치된 세포사는 72시간 후에 MOI of 20에서 대조군 2.5%에 비하여 REN군 32.9%로 상대적으로 높게 나타났다. 또한 REN cell에서의 전구세포사멸 단백질(proapoptotic protein)인 BAX 발현 증가를, BCL-2에서 발현 감소를 나타내었으나, BCL-XL, BAK 및 BAD 단백질은 변화가 없었다. 결론: Adenovirus PTEN을 매개로 한 BAX 발현 증가는 세포사멸을 유도하고 p53에 민감한 중피종 세포들(p53-sensitive methothelioma cells)에서 세포 생존력을 감소시킨다. 이러한 결과는 PTEN 유전자 핵산전달감염하는 것은 중피종 치료의 새로운 대안적 방법이 될 수 있다는 것을 암시한다.

Keywords

References

  1. Cancer Invest v.14 no.5 Mechanisms of carcinogenesis and clinical features of asbestos-associated cancers Mossman,B.T.;Kamp,D.W.;Weitzman,S.A. https://doi.org/10.3109/07357909609018904
  2. Am J Physiol v.275 no.1 Resistance of pleural mesothelioma cell lines to apoptosis: relation to expression of Bcl-2 and Bax Narasiman,S.R.;Yang,L.;Gerwin,B.I.;Broaddus,V.C.
  3. Science v.275 PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer Li,J.Y.;Clifford,L.;Danny,P.(et al.) https://doi.org/10.1126/science.275.5308.1943
  4. Am J Hum Genet v.61 no.6 PTEN : sometimes taking it off can be better than putting it on Myers,M.P.;Tonks,N.K. https://doi.org/10.1086/301659
  5. Cell v.95 no.1 Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN Stambolic,V.;Suzuki,A.;de la Pompa,J.L.(et al.) https://doi.org/10.1016/S0092-8674(00)81780-8
  6. Curr Opin Cell Biol v.10 no.2 Mechanisms and consequences of activation of protein kinase B/Akt Downward,J. https://doi.org/10.1016/S0955-0674(98)80149-X
  7. Science v.280 no.5369 Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN Tamura,M.;Gu,J.;Matsumoto,K.;Aota,S.;Parsons,R.;Yamada,K.M. https://doi.org/10.1126/science.280.5369.1614
  8. Hum Mol Genet v.10 no.6 PTEN coordinates G(1) arrest by down-regulating cyclin D1 via its protein phosphatase activity and up-regulating p27 via its lipid phosphatase activity in a breast cancer model Weng,L.P.;Brown,J.L.;Eng,C. https://doi.org/10.1093/hmg/10.6.599
  9. Exp Cell Res v.256 no.2 Cell cycle arrest by the PTEN tumor suppressor is target cell specific and may require protein phosphatase activity Hlobilkova,A.;Guldberg,P.;Thullberg,M.;Zeuthen,J.;Lukas,J.;Bartek,J. https://doi.org/10.1006/excr.2000.4867
  10. Cell v.79 no.2 Checkpoints of dueling dimers foil death wishes Oltvai,Z.N.;Korsmeyer,S.J. https://doi.org/10.1016/0092-8674(94)90188-0
  11. Science v.267 no.5203 Mechanisms and genes of cellular suicide Steller,H. https://doi.org/10.1126/science.7878463
  12. Cell v.74 no.6 p53-dependent apoptosis modulates the cytotoxicity of anticancer agents Lowe,S.W.;Ruley,H.E.;Jacks,T.;Housman,D.E. https://doi.org/10.1016/0092-8674(93)90719-7
  13. Science v.281 no.5381 The Bcl-2 protein family: arbiters of cell survival Adams,J.M.;Cory,S. https://doi.org/10.1126/science.281.5381.1322
  14. Blood v.88 no.2 Molecular thanatopsis : a discourse on the BCL2 family and cell death Yang,E.;Korsmeyer,S.J.
  15. Science v.275 no.5303 The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis Kluck,R.M.;Bossy-Wetzel,E.;Green,D.R.;Newmeyer,D.D. https://doi.org/10.1126/science.275.5303.1132
  16. FEBS Lett v.415 no.1 Release of cytochrome c and decrease of cytochrome c oxidase in Bax-expressing yeast cells, and prevention of these effects by coexpression of Bcl-xL Manon,S.;Chaudhuri,B.;Guerin,M. https://doi.org/10.1016/S0014-5793(97)01087-9
  17. J Pathol v.81 no.4 Bcl-2 expression in pleural and extrapleural solitary fibrous tumours Chilosi,M.;Facchettti,F.(et al.)
  18. Am J Physiol v.275 Resistance of pleural methothelima cell lines to apoptosis : telation to expression of Bcl-2 and Bax Narasimhan,S.R.;Yang,L.;Gerwin,B.I.;Broaddus,V.C.
  19. Cell v.74 no.4 Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death Oltvai,Z.N.;Milliman,C.L.;Korsmeyer,S.J. https://doi.org/10.1016/0092-8674(93)90509-O
  20. Oncogene v.9 no.6 Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo Miyashita,T.;Krajewski,S.;Krajewska,M.(et al.)
  21. Cancer Gene Ther v.8 no.8 Significant augmentation of pro-apoptotic gene therapy by pharmacologic bcl-xl down-regulation in methothelioma Mohiuddin,I.;Cao,X.;Fang,B.;nishizaki,M.;Smythe,W.R. https://doi.org/10.1038/sj.cgt.7700332
  22. J Thorac Cardiovasc Surg v.121 no.1 Adenovirus-mediated Bak gene transfer induces apoptosis in mesothelioma cell lines Pataer,A.;Smythe,W.R.;Yu,R.(et al.) https://doi.org/10.1067/mtc.2001.111419
  23. Hum Gene Ther v.9 no.7 adenovirus-mediated herpes simplex virus thymidine kinase/ganiciclovir gene therapy in patients with localized malignancy: results of a phaseⅠ clinical trial in malignant mesothelioma Sterman,D.H.;Treat,J.;Litzky,L.A.(et al.) https://doi.org/10.1089/hum.1998.9.7-1083
  24. J Natl Cancer Inst v.91 no.9 Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer Swisher,S.G.;Roth,J.A.(et al.) https://doi.org/10.1093/jnci/91.9.763